Comment: ARM must beware of the 'tied-selling' trap
Peter Clarke, EE Times
(02/24/2010 9:42 AM EST)
LONDON — The success of ARM Holdings plc with its series of low-power processing cores, and its relatively small-scale success — so far — with its Mali graphics processing cores puts ARM in a potentially dangerous position.
ARM (Cambridge, England) gives royalty discounts when additional processor cores are integrated on a single chip. In the era of multicore processor architectures this clearly makes sense as it is applied to dual-core and quad-core Cortex-A9s and even heterogeneous aggregations of ARM cores. However, Warren East, CEO of ARM, has said that discounts are also extended when a chip company includes a Mali graphics core alongside an ARM general purpose processor cores. And therein lies the danger.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
|
Arm Ltd Hot IP
Related News
- Arm Drives Next-Generation Performance for IoT with World's First Armv9 Edge AI Platform
- Arm's power play will backfire
- Arm, ASE, BMW Group, Bosch, Cadence, Siemens, SiliconAuto, Synopsys, Tenstorrent and Valeo commit to join imec's Automotive Chiplet Program
- Arm's calendar Q2 revenues up 39% y-o-y
- Arm China's ex-CEO sets up RISC-V company
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design